GKB Ophthalmics share news, announcements and annual reports
NSE: GKBBSE: 533212Healthcare Equipment & SuppliesSmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹60.50.
29 Oct: open ₹59.80, high ₹62.80, low ₹56.13
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30 Cr3,821st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.33
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.57
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,78558.9% delivered
GKB Ophthalmics has 995 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 22 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.GKB Ophthalmics quarterly results
The board met on 12 Aug 2026 to consider quarterly results
Notice filed 27 Jul 2026
GKB Ophthalmics annual reports, presentations and earnings calls
The company's own documents, latest first.GKB Ophthalmics financials, year by year
Annual reports25
- Annual report, year to Mar 202631 Jul 2026
- Annual report, year to Mar 202529 Jul 2025
- Annual report, year to Mar 202426 Jul 2024
- Annual report, year to Mar 202322 Aug 2023
- Annual report, year to Mar 20227 Sep 2022
20 earlier reports
- Annual report, year to Mar 20213 Sep 2021
- Annual report, year to Mar 20204 Sep 2020
- Annual report, year to Mar 201930 Aug 2019
- Annual report, year to Mar 201828 Aug 2018
- Annual report, year to Mar 201725 Sep 2017
- Annual report, year to Mar 201628 Sep 2016
- Annual report, year to Mar 20154 Sep 2015
- Annual report, year to Mar 201424 Oct 2014
- Annual report, year to Mar 20137 Aug 2013
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 201114 Dec 2011
- Annual report, year to Mar 20102 Dec 2011
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2000Filing day not known
GKB Ophthalmics share news and announcements
Newest first. Page 1 of 20.
Sep 2026
Aug 2026
Jul 2026
31 Jul · Disclosure Of Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015("Listing Regulations')
31 Jul · Corporate action
27 Jul · Board meeting
Meeting on 12 Aug 2026: quarterly results14 Jul · Disclosure Of Information Pursuant To Regulation 30- Update On Case No. 32/09 Filed For Adjudication Of Charter Of Demands
Jun 2026
30 Jun · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
May 2026
4 May · Board meeting
Meeting on 27 May 2026: audited results
Apr 2026
7 Apr · Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018
Mar 2026
18 Mar · Outcome Of Independent Directors' Meeting Held On March 18, 2026
9 Mar · Notice Of The Independent Directors' Meeting
Feb 2026
Jan 2026
30 Jan · Board meeting
Meeting on 12 Feb 2026: quarterly results
Dec 2025
30 Dec · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Nov 2025
21 Nov · Intimation Under Regulation 30 Of SEBI(LODR) Regulation, 2015-Approval Of Voluntary Liquidation Of Material Subsidiary, GSV Ophthalmics Private Limited
20 Nov · Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Voluntary Winding Up Of Material Subsidiary.
Oct 2025
28 Oct · Board meeting
Meeting on 14 Nov 2025: quarterly results11 Oct · Intimation Of Reduction In Production And Manpower At The Company's Plant Situated At Tivim Industrial Estate,Goa.
Sep 2025
22 Sep · Intimation And Board Outcome Regarding Voluntary Liquidation Of Material Subsidiary - GSV Ophthalmics Private Limited - September 22, 2025.
12 Sep · Receipt Of Order - Update On Case No. 32/09 Filed For Adjudication Of Charter Of Demands
Aug 2025
16 Aug · Corrigendum To The Annual Report For The Financial Year 2024-2025.
Jul 2025
31 Jul · Board meeting
Meeting on 14 Aug 2025: quarterly results28 Jul · Corporate action
28 Jul · GKB Ophthalmics Limited- Submission Of Annual Report For The Financial Year 2024-25
How the price met the news
The latest 30. The first session after each announcement, beside the market. Moves to 27 May 2026 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 27 May 2026Credit ratingdown 4.20%−4.5 pts vs Nifty 500market median 0.0% · five sessions −6.1% (−4.2 pts vs Nifty 500) · volume 6.6× usual · The announcement
- 15 Sep 2025Order receiveddown 1.43%−1.5 pts vs Nifty 500market median +1.1% · five sessions −3.1% (−4.4 pts vs Nifty 500) · volume 2.2× usual · The announcement
- 11 Apr 2025Credit ratingup 4.95%+3.0 pts vs Nifty 500market median 0.0% · five sessions +18.8% (+10.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 23 May 2024Board or managers changedup 1.20%0.0 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−1.8 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 21 Mar 2024Board or managers changedup 0.36%−1.0 pts vs Nifty 500market median 0.0% · five sessions +5.2% (+2.0 pts vs Nifty 500) · volume 5.4× usual · The announcement
- 19 Mar 2024Board or managers changeddown 0.78%+0.4 pts vs Nifty 500market median 0.0% · five sessions +11.7% (+10.9 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 31 May 2023Board or managers changeddown 4.99%−4.8 pts vs Nifty 500market median 0.0% · five sessions −22.5% (−23.0 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 2 Apr 2019Board or managers changeddown 2.26%−2.5 pts vs Nifty 500market median 0.0% · five sessions −7.2% (−6.4 pts vs Nifty 500) · volume 18.8× usual · The announcement
- 10 Sep 2018Board or managers changeddown 0.63%+0.1 pts vs Nifty 500market median 0.0% · five sessions −14.7% (−13.5 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 16 May 2016Dividendup 4.71%+5.2 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−1.6 pts vs Nifty 500) · volume 0.2× usual
20 earlier announcements
- 19 May 2015Dividendup 3.73%+3.7 pts vs Nifty 500market median 0.0% · five sessions +9.5% (+9.5 pts vs Nifty 500) · volume 3.5× usual
- 14 Nov 2014Resultsdown 9.94%−10.4 pts vs Nifty 500market median −0.7% · five sessions −25.3% (−26.1 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 14 Aug 2014Resultsup 18.16%+17.4 pts vs Nifty 500market median −0.7% · five sessions +18.6% (+15.8 pts vs Nifty 500) · volume 3.6× usual · The announcement
- 3 Jun 2014Dividenddown 3.45%−4.2 pts vs Nifty 500market median 0.0% · five sessions +14.4% (+9.6 pts vs Nifty 500) · volume 3.9× usual
- 2 Jun 2014Resultsdown 4.84%−5.7 pts vs Nifty 500market median −0.7% · five sessions +3.8% (−0.8 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 13 May 2014Dividendup 3.57%+2.1 pts vs Nifty 500market median 0.0% · five sessions +7.1% (−1.0 pts vs Nifty 500) · volume 5.3× usual
- 12 May 2014Dividend–market median 0.0% · five sessions −12.4% (−21.7 pts vs Nifty 500) · volume 0.0× usual
- 20 Nov 2013Results–market median −0.7% · volume 0.1× usual · The announcement
- 3 Jun 2013Dividenddown 2.03%0.0 pts vs Nifty 500market median 0.0% · five sessions −10.1% (−5.9 pts vs Nifty 500) · volume 0.9× usual
- 8 May 2013Dividend–market median 0.0% · volume 0.1× usual
- 15 Feb 2013Board or managers changeddown 13.66%−13.6 pts vs Nifty 500market median 0.0% · five sessions −14.1% (−13.5 pts vs Nifty 500) · volume 0.4× usual
- 15 Feb 2013Resultsdown 13.66%−13.6 pts vs Nifty 500market median −0.7% · five sessions −14.1% (−13.5 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 13 Aug 2012Resultsdown 7.63%−8.3 pts vs Nifty 500market median −0.7% · five sessions +2.9% (+1.2 pts vs Nifty 500) · volume 2.6× usual · The announcement
- 4 Jun 2012Dividend0.00%0.0 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−5.8 pts vs Nifty 500) · volume 1.1× usual
- 31 May 2012Resultsup 9.87%+10.1 pts vs Nifty 500market median −0.7% · five sessions +21.4% (+20.5 pts vs Nifty 500) · volume 3.9× usual · The announcement
- 30 Apr 2012Dividendup 1.72%+0.6 pts vs Nifty 500market median 0.0% · five sessions +0.3% (+3.7 pts vs Nifty 500) · volume 1.3× usual
- 14 Feb 2012Resultsup 4.87%+4.3 pts vs Nifty 500market median −0.7% · five sessions +15.5% (+11.2 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 6 Sep 2011Dividenddown 4.75%−5.5 pts vs Nifty 500market median 0.0% · five sessions −4.0% (−2.7 pts vs Nifty 500) · volume 2.5× usual
- 18 Aug 2011Dividenddown 8.34%−6.2 pts vs Nifty 500market median 0.0% · five sessions −1.3% (+2.4 pts vs Nifty 500) · volume 0.0× usual
- 14 Feb 2011Resultsup 0.23%−4.6 pts vs Nifty 500market median −0.7% · five sessions +1.1% (−3.1 pts vs Nifty 500) · volume 2.2× usual · The announcement
GKB Ophthalmics results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Revenue from operations | Quarter to Jun 2022 | Standalone | 7.63 | 7.68 | +0.6% | 6 Sep 2022 | 25 Nov 2022 |
| Other income | Quarter to Jun 2022 | Standalone | 0.10 | 0.11 | +1.0% | 6 Sep 2022 | 25 Nov 2022 |
| Total income | Quarter to Jun 2022 | Standalone | 7.74 | 7.79 | +0.6% | 6 Sep 2022 | 25 Nov 2022 |
| Materials used | Quarter to Jun 2022 | Standalone | 3.90 | 3.95 | +1.2% | 6 Sep 2022 | 25 Nov 2022 |
| Other expenses | Quarter to Jun 2022 | Standalone | 1.84 | 1.85 | +0.1% | 6 Sep 2022 | 25 Nov 2022 |
| Total expenses | Quarter to Jun 2022 | Standalone | 7.69 | 7.73 | +0.6% | 6 Sep 2022 | 25 Nov 2022 |